Physician

Carlos Alberto Ramirez-Mejia, MD

According to 2025 Medicare claims, Carlos Ramirez-Mejia, MD (NPI: 1053375360) practices sleep medicine in the Miami-Miami Beach-Kendall, FL market, with the plurality of this provider's patient population coming from Miami-Dade, FL. This provider's primary affiliated billing organization is NEUROSCIENCE CONSULTANTS LLP (NPI: 1346217452; TIN: 542107535) and primary practice location at 33176-2151.

Ramirez-Mejia's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 262 traditional Medicare patients, billed 4,545 HCPCS/CPT codes, and received $145,738 in Medicare payments. The top billing code was 95819 (Measurement of brain wave activity (eeg), awake and asleep). Part D data shows 1,186 prescription claims across 225 beneficiaries totaling $217,835 in drug costs, led by Nurtec Odt (Rimegepant Sulfate). DME data shows 1,025 claims. Open Payments data shows 231 records totaling $5,595. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, reported payments rose steadily, from $13,319 to $43,657.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	304	995	$127,653
2016	308	883	$122,329
2017	303	921	$132,727
2018	302	995	$137,156
2019	278	1,039	$136,628
2020	198	570	$67,211
2021	227	735	$101,721
2022	235	1,995	$129,049
2023	235	2,390	$132,879
2024	262	4,545	$145,738

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	200	1,633	$230,395
2016	204	1,662	$265,247
2017	241	1,926	$291,109
2018	213	1,797	$267,383
2019	229	1,627	$235,033
2020	203	1,507	$218,913
2021	195	1,339	$215,810
2022	219	1,253	$199,463
2023	217	1,186	$396,095
2024	225	1,186	$217,835

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	134	299	$11,726
2016	185	370	$14,617
2017	225	485	$17,240
2018	310	674	$22,830
2019	389	788	$27,288
2020	349	731	$22,753
2021	382	707	$21,788
2022	272	606	$20,645
2023	401	896	$34,997
2024	490	1,025	$43,504

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95819	Measurement of brain wave activity (eeg), awake and asleep	91	92	$369
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	62	62	$170
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	133	203	$149
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	133	190	$98
G0444	Annual depression screening, 5 to 15 minutes	72	72	$19

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Nurtec Odt	Rimegepant Sulfate	16	482	$29,842
Xcopri	Cenobamate	15	451	$15,683
Aimovig Autoinjector	Erenumab-Aooe	16	470	$11,362
Gralise	Gabapentin	12	293	$11,201
Memantine Hcl	Memantine Hcl	179	9,925	$4,757

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0601	Continuous positive airway pressure (cpap) device	Y	52	262	$9,822
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	51	104	$6,029
A7030	Full face mask used with positive airway pressure device, each	N	30	55	$5,272
E0562	Humidifier, heated, used with positive airway pressure device	N	29	29	$4,148
A7032	Cushion for use on nasal mask interface, replacement only, each	N	30	57	$3,907

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	231	$5,595	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Carlos Alberto Ramirez-Mejia, MD?

Tedicare shows public-source Medicare data for Carlos Alberto Ramirez-Mejia, MD (NPI 1053375360), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Carlos Alberto Ramirez-Mejia, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Carlos Alberto Ramirez-Mejia, MD?

Carlos Alberto Ramirez-Mejia, MD is linked to NEUROSCIENCE CONSULTANTS LLP (billing NPI 1346217452) in the available physician profile data.

Does Carlos Alberto Ramirez-Mejia, MD have Open Payments data?

Carlos Alberto Ramirez-Mejia, MD has 231 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.